<DOC>
	<DOCNO>NCT00274599</DOCNO>
	<brief_summary>Demonstrate telmisartan 80mg least effective possibly superior ramipril 5mg &amp; 10mg lower mean ambulatory DBP SBP last 6 hrs 24-hr dose interval mild-to-moderate hypertensive end 8 14 week treatment phase .</brief_summary>
	<brief_title>PROBE Investigation Safety &amp; Efficacy Telmisartan ( Micardis® ) v Ramipril ( Altace® ) Using ABPM HTN</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria />
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>